Fehrman-Ekholm I
Dept of Transplantation and Liver Surgery, Sahlgrenska University Hospital, Göteborg, Sweden.
Transplant Proc. 2006 Oct;38(8):2637-41. doi: 10.1016/j.transproceed.2006.07.027.
Living donor kidney transplantation is the optimum treatment for the uremic patient. Successful kidney transplantations started in 1953 in Boston and in Sweden in 1964. This article showed data on the selection of the donor, surgical techniques for the removal of the kidney, and follow-up of short-term complications. The long-term results included the number of donors who developed hypertension and the few donors who developed end-stage renal failure (ESRF) and the reasons for this. Finally, new groups of donors such as blood group-incompatible donors and anonymous donors have been accepted, each of whom have their own programs. This article also discussed our responsibilities as renal specialists or transplant surgeons for kidney donors at surgery and postsurgery.
活体供肾移植是尿毒症患者的最佳治疗方法。1953年在波士顿以及1964年在瑞典开始了成功的肾移植手术。本文展示了关于供体选择、肾脏摘除手术技术以及短期并发症随访的数据。长期结果包括出现高血压的供体数量以及少数发展为终末期肾衰竭(ESRF)的供体及其原因。最后,诸如血型不相合供体和匿名供体等新的供体群体已被接受,他们各自都有自己的方案。本文还讨论了我们作为肾脏专科医生或移植外科医生在手术中和手术后对肾脏供体的责任。